{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T04:31:27Z","timestamp":1769229087869,"version":"3.49.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.02534","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T04:33:51Z","timestamp":1541133231000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and Fc\u03b3R-Expressing Mice"],"prefix":"10.3389","volume":"9","author":[{"given":"Yuki","family":"Moritoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Tsuneyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shiota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ohsugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe-Xiong","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weici","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Xiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeharu","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahide","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Omokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoo","family":"Saga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Saga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick S. C.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Hirokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/hep.28140","article-title":"Changing nomenclature for PBC: from \u2018cirrhosis\u2019 to \u2018cholangitis\u2019","volume":"62","author":"Beuers","year":"2015","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","article-title":"Primary biliary cirrhosis: an orchestrated immune response against epithelial cells","volume":"174","author":"Gershwin","year":"2000","journal-title":"Immunol Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/hep.1840180315","article-title":"Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis","volume":"18","author":"Nakanuma","year":"1993","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1084\/jem.20010956","article-title":"Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells","volume":"195","author":"Kita","year":"2002","journal-title":"J Exp Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/hep.23783","article-title":"Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis","volume":"52","author":"Lleo","year":"2010","journal-title":"Hepatology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.22736","article-title":"Apotopes and the biliary specificity of primary biliary cirrhosis","volume":"49","author":"Lleo","year":"2009","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/hep.20175","article-title":"Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis","volume":"39","author":"Matsumura","year":"2004","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jaut.2016.10.003","article-title":"Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis","volume":"77","author":"Chung","year":"2017","journal-title":"J Autoimmun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jaut.2017.07.003","article-title":"Development of autoantibodies precedes clinical manifestations of autoimmune diseases: a comprehensive review","volume":"83","author":"Ma","year":"2017","journal-title":"J Autoimmun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2015.08.020","article-title":"Immunity, tolerance and autoimmunity in the liver: a comprehensive review","volume":"66","author":"Doherty","year":"2016","journal-title":"J Autoimmun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.4049\/jimmunol.177.3.1655","article-title":"Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice","volume":"177","author":"Oertelt","year":"2006","journal-title":"J Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jaut.2016.12.012","article-title":"Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8(+) T cell activation","volume":"78","author":"Ma","year":"2017","journal-title":"J Autoimmun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/hep.23238","article-title":"B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice","volume":"50","author":"Moritoki","year":"2009","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hep.25511","article-title":"Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis","volume":"55","author":"Jin","year":"2012","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/2013\/512624","article-title":"Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy","volume":"27","author":"Burak","year":"2013","journal-title":"Can J Gastroenterol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1172\/JCI83840","article-title":"Rituximab does not reset defective early B cell tolerance checkpoints","volume":"126","author":"Chamberlain","year":"2016","journal-title":"J Clin Invest."},{"key":"B18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s10067-015-3166-9","article-title":"Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart review","volume":"35","author":"Contis","year":"2016","journal-title":"Clin Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2217\/nmt.15.67","article-title":"B cell-directed therapies in multiple sclerosis","volume":"6","author":"Gasperi","year":"2016","journal-title":"Neurodegener Dis Manag."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e0150749","DOI":"10.1371\/journal.pone.0150749","article-title":"Rituximab effectiveness and safety for treating Primary Sjogren's Syndrome (pSS): systematic review and meta-analysis","volume":"11","author":"Souza","year":"2016","journal-title":"PLoS ONE"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.4049\/jimmunol.1501755","article-title":"Anti-CD20 antibody with multimerized Fc domains: a novel strategy to deplete B cells and augment treatment of autoimmune disease","volume":"196","author":"Zhang","year":"2016","journal-title":"J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaut.2017.03.004","article-title":"B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis","volume":"81","author":"Amara","year":"2017","journal-title":"J Autoimmun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jaut.2016.11.002","article-title":"B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia","volume":"77","author":"Audia","year":"2017","journal-title":"J Autoimmun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaut.2016.03.012","article-title":"Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFbeta in patients with Multiple Sclerosis","volume":"70","author":"Blumenfeld","year":"2016","journal-title":"J Autoimmun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2016.10.005","article-title":"Impact of tofacitinib treatment on human B-cells in vitro and in vivo","volume":"77","author":"Rizzi","year":"2017","journal-title":"J Autoimmun."},{"key":"B26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jaut.2016.06.002","article-title":"A proliferation inducing ligand (APRIL) promotes IL-10 production and regulatory functions of human B cells","volume":"73","author":"Hua","year":"2016","journal-title":"J Autoimmun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12016-017-8609-4","article-title":"Intracellular B lymphocyte signalling and the regulation of humoral immunity and autoimmunity","volume":"53","author":"Taher","year":"2017","journal-title":"Clin Rev Allergy Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/ajg.2013.51","article-title":"B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid","volume":"108","author":"Myers","year":"2013","journal-title":"Am J Gastroenterol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/hep.24748","article-title":"Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid","volume":"55","author":"Tsuda","year":"2012","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30099","article-title":"Rituximab is ineffective for treatment of fatigue in primary biliary cholangitis: a phase-2 randomised controlled trial","author":"Khanna","year":"2018","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/ard.2007.083162","article-title":"Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus","volume":"67","author":"Albert","year":"2008","journal-title":"Ann Rheum Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1208\/s12248-016-9989-8","article-title":"Magnitude of increased infliximab clearance imposed by anti-infliximab antibodies in Crohn's disease is determined by their concentration","volume":"19","author":"Edlund","year":"2017","journal-title":"AAPS J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1002\/art.20430","article-title":"B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I\/II dose-escalation trial of rituximab","volume":"50","author":"Looney","year":"2004","journal-title":"Arthritis Rheum."},{"key":"B34","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jaci.2012.03.022","article-title":"Inhibitory human antichimeric antibodies to rituximab in a patient with pemphigus","volume":"130","author":"Lunardon","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.clim.2009.05.007","article-title":"Immunogenicity of rituximab in patients with severe pemphigus","volume":"132","author":"Schmidt","year":"2009","journal-title":"Clin Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1002\/art.22046","article-title":"Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment","volume":"54","author":"Smith","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2017.09.002","article-title":"Myelin oligodendrocyte glycoprotein-specific antibodies from multiple sclerosis patients exacerbate disease in a humanized mouse model","volume":"86","author":"Khare","year":"2018","journal-title":"J Autoimmun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s12185-009-0269-6","article-title":"Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura","volume":"89","author":"Goto","year":"2009","journal-title":"Int J Hematol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/art.21260","article-title":"Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study","volume":"52","author":"Pijpe","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard.2006.057919","article-title":"Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjogren's syndrome","volume":"66","author":"Seror","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd3229","article-title":"Development trends for human monoclonal antibody therapeutics","volume":"9","author":"Nelson","year":"2010","journal-title":"Nat Rev Drug Discov."},{"key":"B42","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/cam4.60","article-title":"Novel humanized anti-CD20 antibody BM-ca binds to a unique epitope and exerts stronger cellular activity than others","volume":"2","author":"Kobayashi","year":"2013","journal-title":"Cancer Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1349-7006.2009.01392.x","article-title":"Development of novel humanized anti-CD20 antibodies based on affinity constant and epitope","volume":"101","author":"Uchiyama","year":"2010","journal-title":"Cancer Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3892\/ijo.2010.864","article-title":"BM-ca is a newly defined type I\/II anti-CD20 monoclonal antibody with unique biological properties","volume":"38","author":"Nishida","year":"2011","journal-title":"Int J Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S1074-7613(00)80170-3","article-title":"Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease","volume":"12","author":"Gorelik","year":"2000","journal-title":"Immunity."},{"key":"B46","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2006.09.013","article-title":"Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse","volume":"25","author":"Kamanaka","year":"2006","journal-title":"Immunity."},{"key":"B47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/hep.510240117","article-title":"Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies","volume":"24","author":"Moteki","year":"1996","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/cei.12806","article-title":"Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice","volume":"185","author":"Yang","year":"2016","journal-title":"Clin Exp Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1002\/hep.22226","article-title":"Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice","volume":"47","author":"Yang","year":"2008","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e89647","DOI":"10.1371\/journal.pone.0089647","article-title":"Therapeutic administration of the chemokine CXCL1\/KC abrogates autoimmune inflammatory heart disease","volume":"9","author":"Bachmaier","year":"2014","journal-title":"PLoS ONE"},{"key":"B51","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2353\/ajpath.2009.080350","article-title":"Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1","volume":"174","author":"Omari","year":"2009","journal-title":"Am J Pathol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12016-015-8482-y","article-title":"Animal models of primary biliary cirrhosis","volume":"48","author":"Katsumi","year":"2015","journal-title":"Clin Rev Allergy Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/liv.13554","article-title":"Clonal characteristics of paired infiltrating and circulating B lymphocyte repertoire in patients with primary biliary cholangitis","volume":"38","author":"Tan","year":"2018","journal-title":"Liver Int."},{"key":"B54","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1055\/s-0034-1383728","article-title":"Animal models of primary biliary cirrhosis","volume":"34","author":"Wang","year":"2014","journal-title":"Semin Liver Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/hep.27313","article-title":"Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis","volume":"60","author":"Zhang","year":"2014","journal-title":"Hepatology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.4049\/jimmunol.174.7.4389","article-title":"The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice","volume":"174","author":"Hamaguchi","year":"2005","journal-title":"J Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1053\/j.gastro.2008.11.035","article-title":"B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis","volume":"136","author":"Moritoki","year":"2009","journal-title":"Gastroenterology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/hep.26418","article-title":"Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFbetaRII mice","volume":"58","author":"Kawata","year":"2013","journal-title":"Hepatology."},{"key":"B59","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.4049\/jimmunol.170.12.5897","article-title":"B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: role of TGF-beta 1","volume":"170","author":"Parekh","year":"2003","journal-title":"J Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"e30139","DOI":"10.1371\/journal.pone.0030139","article-title":"CD40-activated B cells can efficiently prime antigen-specific naive CD8+ T cells to generate effector but not memory T cells","volume":"7","author":"Mathieu","year":"2012","journal-title":"PLoS ONE"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00125-018-4597-z","article-title":"B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model","volume":"61","author":"Da Rosa","year":"2018","journal-title":"Diabetologia"},{"key":"B62","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4049\/jimmunol.158.1.475","article-title":"Chemotaxis and IL-8 receptor expression in B cells from normal and HIV-infected subjects","volume":"158","author":"Jinquan","year":"1997","journal-title":"J Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2172-5-15","article-title":"Age-associated alterations in CXCL1 chemokine expression by murine B cells","volume":"5","author":"Hu","year":"2004","journal-title":"BMC Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1111\/ajt.13393","article-title":"Intrarenal B cell cytokines promote transplant fibrosis and tubular atrophy","volume":"15","author":"Tse","year":"2015","journal-title":"Am J Transplant."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/hep.23132","article-title":"Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice","volume":"50","author":"Yoshida","year":"2009","journal-title":"Hepatology"},{"key":"B66","first-page":"113","article-title":"Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis","volume":"21","author":"Martinez","year":"1995","journal-title":"Hepatology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/hep.24526","article-title":"Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis","volume":"54","author":"Tsuda","year":"2011","journal-title":"Hepatology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/1521-4141(200006)30:6<1733::AID-IMMU1733>3.0.CO;2-E","article-title":"A role for IL-5 in the induction of cytotoxic T lymphocytes in vivo","volume":"30","author":"Apostolopoulos","year":"2000","journal-title":"Eur J Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"23348","DOI":"10.1038\/srep23348","article-title":"Deletion of galectin-3 enhances xenobiotic induced murine primary biliary cholangitis by facilitating apoptosis of BECs and release of autoantigens","volume":"6","author":"Arsenijevic","year":"2016","journal-title":"Sci Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"753483","DOI":"10.1155\/2014\/753483","article-title":"Involvement of IL-13 and tissue transglutaminase in liver granuloma and fibrosis after schistosoma japonicum infection","volume":"2014","author":"Tang","year":"2014","journal-title":"Mediators Inflamm."},{"key":"B71","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12016-012-8323-1","article-title":"Immunological orchestration of liver fibrosis","volume":"43","author":"Tanaka","year":"2012","journal-title":"Clin Rev Allergy Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/hep.23664","article-title":"Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis","volume":"52","author":"Zhang","year":"2010","journal-title":"Hepatology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fimmu.2016.00021","article-title":"Immunogenicity to biotherapeutics - the role of anti-drug immune complexes","volume":"7","author":"Krishna","year":"2016","journal-title":"Front Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"e007985","DOI":"10.1136\/bmjopen-2015-007985","article-title":"RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial","volume":"5","author":"Jopson","year":"2015","journal-title":"BMJ Open."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02534\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T17:52:06Z","timestamp":1694022726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.02534\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":74,"alternative-id":["10.3389\/fimmu.2018.02534"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.02534","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,2]]},"article-number":"2534"}}